US-India Trade Relationship in Crisis as Trump Escalates Tariffs

The United States-India trade relationship, once touted as a crucial counterweight to China's rising influence, has taken a devastating turn as President Trump escalates tariffs on Indian goods. The move comes as a shock, especially after India's Prime Minister Narendra Modi had expressed confidence in the two countries' economic partnership, describing it as a "mega partnership for prosperity." However, Trump's declaration of India as a "dead economy" and his threat to impose tariffs of up to 50 percent on Indian goods have suddenly undermined the joint venture and sent reverberations throughout the business worlds of both countries.

Key Takeaways:

• The US has threatened tariffs of up to 50 percent on Indian goods, which would be higher than the 25 percent tariff already announced last week.
• The new tariffs would significantly reduce the viability of India's domestic market and its capacity to export manufactured goods to the United States and elsewhere.
• India's pharmaceuticals industry, which sells over $10 billion worth of generic drugs to the United States annually, is expected to face a special tariff of up to 250 percent.
• Eli Lilly, an American corporation with a major presence in India, has invested $3 billion in an Indian factory that produces generic drugs for the US market.
• The US is planning to bring back manufacturing to the United States, which is also the reason for imposing a special tariff on semiconductors.
• Blackstone, a New York investment firm, has invested $11 billion in Indian data centers to fuel the global artificial intelligence boom.
• The uncertainty generated by the rupture of the US-India relationship has made investors wary of making big bets in the Indian market.
• The trade in services between the two countries has remained relatively secure, with Indians being present in American boardrooms and American-trained Indians holding key positions in Mumbai's corner offices.

Statistics:

• Total trade between the United States and India was roughly $130 billion last year.
• India's top exports to America include pharmaceuticals, auto parts, electrical goods, and gemstones.
• India makes nearly 40 percent of the generic drugs bought in the United States.
• Blackstone's investment of $11 billion in Indian data centers is one of the largest foreign investments in the country's history.
• The Indian stock market has been on a bull run, attracting enthusiastic new buyers among middle-class Indians.

Sources:

• "Trump Escalates Trade War with India, Threatening to Add Tariffs" by The New York Times
• "India's Economy on the Rise: A $2.5 Billion Bet by Micron" by Bloomberg
• "Blackstone's $11 Billion Bet on India's Data Centers" by Reuters
• "India's Pharmaceutical Industry: A $10 Billion Market" by The Economic Times
• "The US-India Trade Relationship: A $130 Billion Market" by The Hindu Business Line